课题基金 / 基金详情

Pre-clinical studies of a small-molecule to reverse neurodegenerative disease-causing mutations for its commercialization and application

Pre-clinical studies of a small-molecule to reverse neurodegenerative disease-causing mutations for its commercialization and application
逆转神经退行性疾病引起的突变的小分子的临床前研究及其商业化和应用
批准号:
490424
负责人:
Pearson Christopher E
金额:
$52.39万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2026-09-01

项目摘要

项目成果

Pearson Christopher E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Huntington's disease (HD) is caused by mutations in repeated DNAs. If one considers a gene as though it were a sentence such as THE CAT ATE THE FAT RAT, typical mutations would be spelling errors, like THE GAT ATE THE FAT RAT. This mutation would be the s
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FAN1, a DNA repair nuclease, as a modifier of disease-associated repeat instability.
  • 批准号:
    462785
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.66万
  • 财政年份:
    2022
  • 负责人:
    Pearson Christopher E
  • 依托单位:
DNA repair proteins as modifiers of CAG repeat instability in Huntington's disease
  • 批准号:
    420949
  • 项目类别:
    Operating Grants
  • 资助金额:
    $70.22万
  • 财政年份:
    2020
  • 负责人:
    Pearson Christopher E
  • 依托单位:
Somatic DNA mosaicism of the ADNP gene in cells, ADNP-mouse tissues and tissues of a post-mortem ADNP individual: An indication of how this may affect disease.
  • 批准号:
    387299
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.39万
  • 财政年份:
    2018
  • 负责人:
    Pearson Christopher E
  • 依托单位:
Canada Research Chair - Tier 1
  • 批准号:
    404349
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2018
  • 负责人:
    Pearson Christopher E
  • 依托单位:
海外基金